Applied use of venovenous extracorporeal membrane oxygenation support insevere septic shock andsepsis induced cardiomyopathywithunknownetiology pneumonia: a case report
Fengyuan Li1a, Lin Yang1a, Jiahao Chen1a, Qiang Guo1b
a These authors contributed equally to this work.
b Corresponding author
1Department of Medicine, Respiratory, Emergency and Intensive Care Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China 215006
Running title: Applied use of V-V ECMO in septic shock and associated septic cardiomyopathy with unknown etiology pneumonia
Address Correspondence to:
Qiang Guo, M.D. Ph.D.
Department of Medicine, Respiratory, Emergency and Intensive Care Medicine, The First Affiliated Hospital of Soochow University
188 Shizhi st
Suzhou, China 215006
E-mail: dr_qiangguo@163.com
ABSTRACT
BACKGROUD: There is no consensus over the effect of V-V ECMO on septic patients with sepsis-induced cardiomyopathy.
CASE PRESENTATION:A 48-year-old male was transferred to our emergency department for acute-onset fever lasting for four days on November 1, 2019. He traveled in many places in northern China (Yan’an, Beijing, Qinhuangdao and so on) one month prior to admission. We initiated V-V ECMO on day 2. The patient’s hemodynamics and infection condition improved. After detecting of nasopharyngeal swabs and bronchoalveolar lavage samples, A/H1N1 influenza, influenza B, coronavirus, System Inflammatory Reaction Syndrome (SIRS), Middle East respiratory syndrome (MERS) and other epidemic disease were ruled out. On the day 22, patient’s pulmonary images findings revealed the recover. He was transferred to a regular room discharged soon.
CONCLUSION:The outcome of our patient shows that V-V ECMO may also benefit the patient when managing septic shock and septic cardiomyopathy.
KEY WORDS: Extracorporeal membrane oxygenation, sepsis, shock, unknown etiology pneumonia